Testing It Up » April 30, 2016

Daily Archives: April 30, 2016

Medical Marijuana Substance Abuse

Marijuana Legalization in the U.S.

Published by:

While many people are aware of the dangers of marijuana for recreational purposes, many states are pushing for the legalization of medical marijuana. Several studies of cannabinoid compounds have revealed its medicinal qualities, which have further fueled the call for legalizing medical marijuana.

What is Medical Marijuana?

Medical marijuana refers to the treatment of a disease or symptom using the whole unprocessed plant of marijuana or its basic extracts. The U.S. Food and Drug Administration (FDA) has not yet given its stamp of approval or recognition to the use of the marijuana plant as medicine.

However, scientific studies of marijuana chemicals called cannabinoids resulted to a couple of FDA-approved medications that contain cannabinoid chemicals in the form of a pill. Because the marijuana plant contains chemicals useful for the treatment of a wide range of illnesses or symptoms, many people are calling for the legalization of marijuana for medical purposes. In some states, medical marijuana has already been legalized.

Health Benefits

Medical marijuana comes in a variety of forms. It can be smoked, vaporized, or taken as a pill. It may also be prepared as edible foods such as brownies, cookies, and chocolate bars.

The Federal Drug Enforcement Administration classifies marijuana as a Schedule 1 drug, which means that it has a high potential for abuse and with no legitimate medical uses. However, the idea that marijuana may have therapeutic uses is based in solid science. The body has the natural ability to manufacture its own cannabinoids designed for modulating pain.

The main psychoactive cannabinoid in marijuana is tetrahydrocannabinol or THC. It targets the CB1 receptor, a cannabinoid receptor located in the brain as well as in the nervous system, liver, kidney, and lungs. This receptor is activated to silence the body’s response to pain and noxious chemicals.

medical marijuana legalization

Medical marijuana: Is it the miracle cure that millions of patients are looking for?

In a placebo-controlled study published in the journal Neurology, Abrams and his colleagues discovered that marijuana is effective at lowering neuropathic pain caused by damaged nerves. Opiates, such as morphines, are not effective at treating neuropathic pain.

Another study revealed that marijuana, aside from opiates, caused dramatic levels of pain relief. Researchers at the American Academy of Neurology revealed that medical marijuana in the form of pills or oral sprays had the ability to reduce stiffness and muscle spasm.

In addition, the medications also reduced certain symptoms of pain associated with spasms, painful burning and numbness, as well as overactive bladder, according to another study.

One of the well-known effects of using marijuana is the “munchies,” which is used to stimulate appetite among HIV/AIDS patients and others with suppressed appetite after a medical condition or treatment. Medical marijuana is also frequently used for treatment of nausea induced by chemotherapy, although scientific studies of smoked marijuana are limited.

Two FDA-approved chemically altered forms of THC, namely dronabinol and nabilone, have been proven to lower reduce chemotherapy-related nausea and vomiting in cancer patients.

Medical marijuana may also be used for treating glaucoma, an elevated pressure in the eyeball that can result to blindness. The American Cancer Society revealed that while marijuana can decrease intra-ocular pressure, it must be taken several times during the day in order to produce the desired effect.

Cannabidiol (CBD) is a non-psychoactive component of marijuana that contains medicinal benefits. However, since it does not target the CB1 receptor, it does not leave people feeling stoned.

In a 2012 study published in the Journal Translational Psychiatry, it was revealed that cannabidiol can be effective as a treatment for schizophrenia. In a study conducted at the University of Cologne, 42 patients randomly received either cannabidiol or amisulpride, an effective drug used for treating schizophrenia for 28 days. When compared, clinical effects revealed “no relevant difference” between the two treatments.

Side Effects

The active compound in marijuana binds itself to cannabinoid receptors, located in the areas of the brain associated with thinking, memory, pleasure, coordination, and time perception. Its effects can disrupt attention, judgment, and balance.

Meanwhile, studies have produced different results on whether smoking marijuana can have a significant cancer risk.

Short-term

When smoking marijuana, THC can quickly pass from the lungs into the bloodstream. The blood transfers the chemical to the brain and other organs in the body. When eating or drinking it, the body absorbs THC more slowly with the user generally feeling the effects within 30 minutes to 1 hour.

THC acts on specific brain cell receptors that naturally respond to natural THC-like chemicals in the brain. These natural chemicals play a role in the normal functioning and development of the brain.

Marijuana over-activates that area of the brain that contains the biggest number of receptors. It is responsible for causing the “high” that marijuana users experience. It can bring about other effects such as:

  • impaired senses (for example, seeing brighter colors)
  • impaired sense of time
  • mood changes
  • impaired body movement
  • difficulty with thinking and problem-solving
  • impaired memory

Long-term

Marijuana may have adverse effects on brain development. When used as early as teenage years, it can reduce thinking, memory, and learning functions and may affect how the brain connects between the areas needed for these functions. The effects on these areas of the brain can be long-term or even permanent.

One study revealed that people who were heavy marijuana smokers during their teens and currently has cannabis use disorder lost an average of eight IQ points between 13 and 38 years old. The lost mental skills did not completely return even after they stopped smoking marijuana as an adult. On the other hand, those who began smoking marijuana as adults did not show a notable decline in their IQ.

Medical Marijuana Legalization By States

As of April 2016, there are 24 U.S. states that have legalized medical marijuana: Alaska, Arizona, California, Colorado, Connecticut, Delaware, the District of Columbia, Guam, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New York, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington.

California was the very first state that legalized medical marijuana in 1996. From the list of 24 states above, Pennsylvania was the latest state that legalized medical marijuana. Meanwhile, New York legalized the vaporized form of medical marijuana in 2014.

As for recreational marijuana, only four states have so far legalized it: Alaska, Colorado, Oregon, and Washington. It is likely that 11 more states will also legalize recreational marijuana in the near future.

All the 24 states require the approval of a doctor. With the exception of Washington, all states require an identification card to be shown at the dispensary in a patient registry. In most of the states where medical marijuana is legal, there is an online application process.

In majority of the states, patients are required to fill up an application form, pay the necessary fee, and provide identification information. In order to receive an identification card, the patients are required to get a signed statement from a doctor who diagnosed the condition and proof that medical marijuana was the recommended form of treatment for the patient’s particular condition and situation.

In states where medical marijuana is legal, laws permit dispensaries and outline certain conditions for medical marijuana prescription. The restrictions on the format and amount of medical cannabis allowed for personal use in every visit may vary from one state to another.

marijuana legalization in the U.S.

Only time will tell if the entire U.S. legalizes marijuana for medical purposes.

In New York, medical marijuana is highly regulated and legalized for just a few medical conditions, such as epilepsy and cancer. In California, the law applies only for conditions such as arthritis, migraine, and other conditions for which marijuana can offer relief. As such, California legalizes medical marijuana for a wide range of conditions, ranging from insomnia to substance abuse.

In the District of Columbia, recreational marijuana has been decriminalized so residents are allowed to carry up to two ounces of cannabis and own six plants. However, it is still illegal to purchase pot in the District.

The expensive nature of incarceration is one factor that is stopping states from decriminalizing cannabis. In an interview with Vice News, President Obama said that it would require a huge amount of money.

“It costs a huge amount of money to states,” Obama said, speaking to Vice’s Shane Smith. “What I’m encouraged by is you’re starting to see not just liberal democrats but also some very conservative Republicans recognize that this doesn’t make sense, including the libertarian wing of the Republican Party. They see the money and how costly it is to incarcerate. At a certain point, if enough states end up decriminalizing, Congress may then reschedule marijuana.”

On the other hand, legalizing recreational marijuana has paved the way for a whole new economy involving the sale of cannabis, oils, lotions, edibles, and other paraphernalia. Efforts to promote new related businesses have started to emerge supporting these industries despite the regulations state by state. The states that have set the pace in the cannabis market are starting to reap the fruits in the form of tax revenues.

In Colorado, marijuana-specific tax revenue has reached $70 million during the last fiscal year. This was two times higher than what the state earned from alcohol tax revenues.

Throughout the U.S., sales of legal marijuana reached $2.7 billion in 2014, an increase from $1.5 billion the previous year, as reported by cannabis investment and research company ArcView Group. If all 50 states as well as District of Columbia were to legalize marijuana, the U.S. marijuana retail market could exceed the $35 billion plateau by 2020, based on estimates by independent research firm GreenWave Advisers.

The clamor for legalizing marijuana is growing, according to a new survey conducted by the AP-NORC Center for Public Affairs Research published in The Washington Post. The study revealed that a record 61 percent of Americans support legalization of marijuana. A similar survey conducted by Gallup reflected a 58 percent support for legalization.

—————————————

Marijuana has risen in popularity amidst controversies and the tendency for abuse and addiction. As the road to marijuana legalization continues to be paved, only time will tell whether the entire U.S. and other countries will follow suit.